Does EVOLOCUMAB Cause Product administration error? 565 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 565 reports of Product administration error have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.4% of all adverse event reports for EVOLOCUMAB.
565
Reports of Product administration error with EVOLOCUMAB
0.4%
of all EVOLOCUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Product administration error From EVOLOCUMAB?
Of the 565 reports, 11 (1.9%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Product administration error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 565 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Product administration error?
HYDROXYPROGESTERONE CAPROATE (972)
ACETAMINOPHEN (666)
CENEGERMIN-BKBJ (613)
LEUPROLIDE (595)
ADALIMUMAB (543)
METHYLPHENIDATE (414)
OLMESARTAN MEDOXOMIL (314)
ASPIRIN (241)
SECUKINUMAB (225)
HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL (222)
Which EVOLOCUMAB Alternatives Have Lower Product administration error Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE